---
title: "D.A. Davidson Keeps Their Buy Rating on Diebold Nixdorf Inc (DBD)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285080619.md"
description: "D.A. Davidson analyst Matt Summerville has maintained a Buy rating on Diebold Nixdorf Inc (DBD) with a price target of $100.00. The analyst, who specializes in the Industrials sector, has an average return of 18.0% and a success rate of 56.12% on his stock recommendations. The current consensus on Diebold Nixdorf Inc is a Moderate Buy, also with an average price target of $100.00."
datetime: "2026-05-04T13:15:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285080619.md)
  - [en](https://longbridge.com/en/news/285080619.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285080619.md)
---

# D.A. Davidson Keeps Their Buy Rating on Diebold Nixdorf Inc (DBD)

D.A. Davidson analyst Matt Summerville reiterated a Buy rating on Diebold Nixdorf Inc today and set a price target of $100.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Summerville covers the Industrials sector, focusing on stocks such as Crane NXT, IDEX, and Napco Security Technologies. According to TipRanks, Summerville has an average return of 18.0% and a 56.12% success rate on recommended stocks.

Currently, the analyst consensus on Diebold Nixdorf Inc is a Moderate Buy with an average price target of $100.00.

### Related Stocks

- [DBD.US](https://longbridge.com/en/quote/DBD.US.md)
- [CXT.US](https://longbridge.com/en/quote/CXT.US.md)
- [IEX.US](https://longbridge.com/en/quote/IEX.US.md)
- [NSSC.US](https://longbridge.com/en/quote/NSSC.US.md)

## Related News & Research

- [Oversold Conditions For Diebold Nixdorf (DBD)](https://longbridge.com/en/news/286966304.md)
- [Diebold Nixdorf, Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now](https://longbridge.com/en/news/284997390.md)
- [This Analyst Just Sent Mobileye Stock Down. Here's Why.](https://longbridge.com/en/news/286817003.md)
- [LifeSci Capital Sticks to Their Buy Rating for Olema Pharmaceuticals (OLMA)](https://longbridge.com/en/news/286679129.md)
- [Do Wall Street Analysts Like Equity Residential Stock?](https://longbridge.com/en/news/286806057.md)